RxDoctor Payments Data

Colby Doepel, NP

Nurse Practitioner · Atlanta, GANPI 1306013578

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (37.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by EMD Serono, Inc. at 41.0% of the total. Reporting peaked in 2024 at $5,549 and has fallen 75.8% since, to $1,341 in 2025. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,691in general payments, 2019–2025

Across 275 payments — averaging $57.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$6K
  • Amgen$5K
  • Genentech USA, Inc.$2K
  • TG Therapeutics, Inc.$2K
  • Biogen$305
  • Novartis$268
  • plus $923 from 11 others

What the payments were for

  • Consulting fees$5,84837%
  • Speaking & faculty fees$3,20020%
  • Travel & lodging$1,3639%
  • Food & beverage$5,25834%
  • Education$220%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,691 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$8,818
Medicare patients
128
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin18$1,346
Baclofen18$608
Gabapentin29$462
Tizanidine Hcl14$209
Zolpidem Tartrate25$132
Clonazepam31$55
Tramadol Hcl20$48

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →